人类莱什曼病分子和免疫诊断测试的全球景观:系统性审查和元分析
Mayron Antonio Candia-Puma1,2, Brychs Milagros Roque-Pumahuanca1,2, Laura Yesenia Machaca-Luque1,2
1Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa 04000, Peru.
Pathogens (Basel, Switzerland)
|November 27, 2025
概括
准确诊断莱什曼病症至关重要. 分子测试为体莱什曼病 (TL) 和内脏莱什曼病 (VL) 提供了很高的准确性,尽管在流行地区存在实施挑战.
科学领域:
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 莱什曼病是一种严重的全球健康问题.
- 准确的诊断对于有效的治疗至关重要,但仍然具有挑战性.
- 当前的诊断方法往往涉及多个测试.
研究的目的:
- 系统地审查和对莱什曼病的诊断测试进行元分析.
- 评估TL和VL分子和免疫学测试的准确性和适用性.
主要方法:
- 从1990-2021年对研究进行系统审查和元分析.
- 在PubMed数据库中搜索相关研究.
- 包括165项关于分子和免疫学诊断测试的研究.
主要成果:
- 基于PCR的测试显示出高准确度 (TL的AUC为0.919,VL为0.965).
- 对TL的血清测试显示灵敏度为83.3-88.1%,特异性为82.0-92.4%.
- 对于VL,DAT和ELISA具有高灵敏度 (93.0-93.8%) 和特异性 (95.5-96.9%),DAT的性能与分子测试相美.
结论:
- 分子测试对莱什曼病的诊断具有高度准确性.
- 实施障碍包括需要专门的基础设施和在特有地区的专业知识.
- 建议采用量身定制的诊断策略,可能将分子方法整合到早期和精确的诊断中.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


